Recent studies have revealed metastatic and protumorigenic properties of STRN4 in several tum or etiologies including colorectal and prostate cancer as well as non–small cell lung cancer (NSCLC) (42–45). The gene discussed is STRN4; the disease is Familial prostate cancer.